EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 37 / No 2 (June 2005) J Extra Corpor Technol, 37 2 (2005) 153-156 References
Free Access
Issue
J Extra Corpor Technol
Volume 37, Number 2, June 2005
Page(s) 153 - 156
DOI https://doi.org/10.1051/ject/200537153
Published online 15 June 2005
  1. Bennet N, Dodd T, Flatley J, Freeth S, Bolling K. Health Survey for England 1993. London: HMSO; 1995. [Google Scholar]
  2. Centre for Obesity Surgery St James’s Hospital Leeds. UK www.obesitysurgery.org.uk/: Obesity: The Disease [Google Scholar]
  3. Chemoyl G. Clinical Pharmacokinetics of drugs in obesity. An update. Clin Pharmacokinet. 1993;25:103–14. [CrossRef] [PubMed] [Google Scholar]
  4. Trossaert M, Gaiilard A, Commin PL, Amiral J, Vissac AM, Fressinaud E. High incidence if anti-heparin / platelet factor 4 antibodies after cardiopulmonary bypass. Br J Haematol. 1998;101:653–5. [CrossRef] [PubMed] [Google Scholar]
  5. Kimmel SE, Sekeres MA, Berlin JA, Goldberg LR, Strom BL. Adverse effects after protamine administration in patients undergoing cardiopulmonary bypass: risk predictors of under-reporting. J Clin Epidemiol. 1998;51:1–10. [CrossRef] [Google Scholar]
  6. Ionue S, Miyashita T, Kuro M. A case of twice catastrophic pulmonary vasoconstriction-type shock induced with protamine sulphate. Masui. 1997;46:987–90. [PubMed] [Google Scholar]
  7. Tevaearai HT, Jegger D, Mueller XM, Horisberger J, von Segesser LK. Heparin removal after cardiopulmonary bypass in a patient with adverse reaction to protamine. Thorac Cardiovasc Surg. 1998;46:303–4. [CrossRef] [PubMed] [Google Scholar]
  8. Morgan DJ, Bray KM. Lean body mass as a predictor of drug dosage. Implications for drug therapy. Clin Pharmacokinet. 1994;26:292–307. [CrossRef] [PubMed] [Google Scholar]
  9. Brown ME, Gallagher JM, Armitage JM. The use of Human antithrombin lll concentrate for treatment of heparin resistance during cardiopulmonary bypass. J Extra Corpor Technol. 2000;32:75–8. [Google Scholar]
  10. Olsson P, Lagergren H, Ek S. The elimination from plasma of intravenous heparin: an experimental study on dogs and humans. Acta Med Scand. 1963;173:619–30. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.